Sunovion Pharmaceuticals Inc. Announces Initiation of Phase 3 Clinical Trial Program for SUN-101/eFlow® (Glycopyrrolate) in Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease (COPD)
Posted Conference Call for Third Quarter Financial Results for FY2014 [Webcast]
"Corporate profile" An English version and a Japanese version are updated.
Presentation Material (Third Quarter Financial Results for FY2014)
Supplementary Financial Data for the Third Quarter of the Year Ending March 31, 2015
Summary of Consolidated Financial Results for the Third Quarter of the Year Ending March 31, 2015 [Japanese GAAP] (Unaudited)
A Message from the President
Board of Directors and Executive Officers